These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38322226)

  • 1. The global burden of fatty liver disease: the major impact of China.
    Lou TW; Yang RX; Fan JG
    Hepatobiliary Surg Nutr; 2024 Feb; 13(1):119-123. PubMed ID: 38322226
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink.
    Ferreira G; Stuurman AL; Horsmans Y; Cattaert T; Verstraeten T; Feng Y; Rosillon D; Guignard A
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):101-109. PubMed ID: 31651649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.
    Khalili M; King WC; Kleiner DE; Jain MK; Chung RT; Sulkowski M; Lisker-Melman M; Wong DK; Ghany M; Sanyal A; Sterling RK
    Clin Infect Dis; 2021 Nov; 73(9):e3275-e3285. PubMed ID: 32869840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
    Fan JG
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():11-7. PubMed ID: 23855290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
    Khalili M; King WC; Kleiner DE; Chung RT; Bhan AK; Ghany MG; Sulkowski MS; Lisker-Melman M; Jain MK; Janssen HLA; Hinerman AS; Sanyal AJ; Sterling RK
    Clin Infect Dis; 2022 Jun; 74(11):1914-1924. PubMed ID: 34698347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
    Li H; Wang YJ; Tan K; Zeng L; Liu L; Liu FJ; Zhou TY; Chen EQ; Tang H
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):377-82. PubMed ID: 19666406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus.
    Xu J; Wu L; Deng J; Yang L; Wang Y; Tian H; Ji Y; Xia Q; Han Z; Cheng Y; Lu X
    BMC Endocr Disord; 2023 Sep; 23(1):201. PubMed ID: 37726718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Effect of Smoking and Fatty Liver Disease on the Progression of Type 2 Diabetes: Insights from a Population-Based Cohort Study.
    Zhang T; Zhang D; Zeng J; Yang Y; Fang Y; Wang X
    Comput Math Methods Med; 2022; 2022():1776875. PubMed ID: 35855836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal transaminase and lipid profiles in coexisting diseases in patients with fatty liver: a population study in Sichuan.
    Jiang W; Liu CH; Wu D; Wang YJ; Tang H
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34918746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection.
    Liu CH; Jiang W; Wu DB; Zeng QM; Wang YJ; Tang H
    Dig Dis Sci; 2023 Apr; 68(4):1605-1614. PubMed ID: 36227429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and molecular analysis on the relationships between type 2 diabetes mellitus and hepatitis B virus infection.
    Zhu H; Wang Y; Yu L; Xu Y; Zhou H; Ding Y; Wang A; Liu X; Dong C
    J Infect Dev Ctries; 2016 Aug; 10(8):837-44. PubMed ID: 27580329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD.
    Park SH; Park J; Kwon SY; Lee YB; Kim G; Hur KY; Koh J; Jee JH; Kim JH; Kang M; Jin SM
    Sci Rep; 2023 Jul; 13(1):10677. PubMed ID: 37393407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and risk factors for fatty liver disease in a professional population of Wuhan, China.
    Dai H; Chu L; Song S; Li W; Zhang L; Wu Z; Zeng J; Duan Q
    Public Health; 2009 Aug; 123(8):545-8. PubMed ID: 19674763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.
    Younossi Z; Kochems K; de Ridder M; Curran D; Bunge EM; de Moerlooze L
    Hum Vaccin Immunother; 2017 Nov; 13(11):2695-2706. PubMed ID: 28742983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of chronic liver diseases in the USA in the past three decades.
    Younossi ZM; Stepanova M; Younossi Y; Golabi P; Mishra A; Rafiq N; Henry L
    Gut; 2020 Mar; 69(3):564-568. PubMed ID: 31366455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Hepatitis B Collaborators
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):796-829. PubMed ID: 35738290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Khalili M; Kleiner DE; King WC; Sterling RK; Ghany MG; Chung RT; Bhan AK; Rosenthal P; Lisker-Melman M; Ramachandran R; Lok AS;
    Am J Gastroenterol; 2021 Aug; 116(8):1686-1697. PubMed ID: 33840726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
    Doycheva I; Zhang T; Amjad W; Thuluvath PJ
    J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
    Zhang XP; Chai ZT; Feng JK; Zhu HM; Zhang F; Hu YR; Zhong CQ; Chen ZH; Wang K; Shi J; Guo WX; Chen CS; Wu MC; Lau WY; Cheng SQ
    Eur J Surg Oncol; 2022 Jan; 48(1):142-149. PubMed ID: 34452770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.